M1 Kliniken AG (FRA:M12)

M1 Kliniken AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	339.18	316.32	285.29	314.61	159.59
Revenue Growth (YoY)	7.23%	10.88%	-9.32%	97.14%	106.68%
Cost of Revenue	295.76	283.85	254.06	281.89	139.79
Gross Profit	43.42	32.47	31.23	32.72	19.8
Selling, General & Admin	2.34	1.98	1.66	1.67	1.85
Other Operating Expenses	9.81	9.82	14.57	13.23	9.07
Operating Expenses	17.37	17.11	22.29	20.59	15.4
Operating Income	26.05	15.37	8.94	12.14	4.4
Interest Expense	-1.93	-1.35	-0.83	-0.92	-0.72
Interest & Investment Income	0.99	2.1	1.5	1.87	0.3
Earnings From Equity Investments	-	-	-	-	1.92
Currency Exchange Gain (Loss)	0.23	-0.07	-0.07	-0.3	-0.18
Other Non Operating Income (Expenses)	0.37	0.01	0.26	0.04	0.01
EBT Excluding Unusual Items	25.71	16.06	9.81	12.84	5.73
Gain (Loss) on Sale of Investments	0.48	-0	0.22	1.33	-1.83
Gain (Loss) on Sale of Assets	0.07	0.24	0.01	0.01	-0.35
Other Unusual Items	-	-	-	-	5.08
Pretax Income	26.3	16.45	10.23	14.42	8.78
Income Tax Expense	8.51	4.78	3.16	3.54	1.35
Earnings From Continuing Operations	17.79	11.67	7.07	10.88	7.42
Minority Interest in Earnings	-1.77	-1.39	-2.75	-1.97	-0.6
Net Income	16.02	10.27	4.32	8.91	6.82
Net Income to Common	16.02	10.27	4.32	8.91	6.82
Net Income Growth	55.91%	137.98%	-51.52%	30.52%	-29.87%
Shares Outstanding (Basic)	19	19	18	19	19
Shares Outstanding (Diluted)	19	19	18	19	19
Shares Change (YoY)	-1.82%	4.43%	-1.43%	-0.02%	6.19%
EPS (Basic)	0.85	0.54	0.24	0.48	0.37
EPS (Diluted)	0.85	0.54	0.24	0.48	0.37
EPS Growth	58.79%	127.89%	-50.82%	30.54%	-33.96%
Free Cash Flow	30.32	7.35	19.61	14.66	8.63
Free Cash Flow Per Share	1.61	0.39	1.07	0.79	0.47
Dividend Per Share	0.500	0.500	-	-	-
Gross Margin	12.80%	10.27%	10.95%	10.40%	12.41%
Operating Margin	7.68%	4.86%	3.14%	3.86%	2.76%
Profit Margin	4.72%	3.25%	1.51%	2.83%	4.28%
Free Cash Flow Margin	8.94%	2.33%	6.87%	4.66%	5.41%
EBITDA	27.45	16.92	10.6	14.42	5.72
EBITDA Margin	8.09%	5.35%	3.71%	4.58%	3.58%
D&A For EBITDA	1.39	1.55	1.65	2.29	1.32
EBIT	26.05	15.37	8.94	12.14	4.4
EBIT Margin	7.68%	4.86%	3.14%	3.86%	2.76%
Effective Tax Rate	32.35%	29.06%	30.91%	24.57%	15.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.